. "Appendix B: Invited Participants at the August 7, 2009, Meeting of the Human Embryonic Stem Cell Research Advisory Committee." Final Report of The National Academies' Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to The National Academies' Guidelines for Human Embryonic Stem Cell Research. Washington, DC: The National Academies Press, 2010.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Final Report of the National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research
Appendix B Invited Participants at the August 7, 2009,Meeting of the Human Embryonic Stem CellResearch Advisory Committee
GEORGEQ. DALEY, Samuel E. Lux IV Chair in Hematology and Director, Stem Cell Transplantation Program, Children’s Hospital Boston; Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Investigator, Howard Hughes Medical Institute; and Past President, International Society for Stem Cell Research
DEBORAHA. HURSH, Senior Investigator, Division of Cellular and Gene Therapies, Center for Biologics Research and Review, U.S. Food and Drug Administration
JULIEKANESHIRO, Team Leader, Policy, Office for Human Research Protections, Department of Health and Human Services
STORYLANDIS, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Chair, NIH Stem Cell Task Force
BERNARDLO, Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco
GEOFFLOMAX, Senior Officer to the Standards Working Group, California Institute for Regenerative Medicine
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 17
Final Report of the National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research
Appendix B
Invited Participants at the August 7, 2009, Meeting of the Human Embryonic Stem Cell Research Advisory Committee
GEORGE Q. DALEY, Samuel E. Lux IV Chair in Hematology and Director, Stem Cell Transplantation Program, Children’s Hospital Boston; Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Investigator, Howard Hughes Medical Institute; and Past President, International Society for Stem Cell Research
DEBORAH A. HURSH, Senior Investigator, Division of Cellular and Gene Therapies, Center for Biologics Research and Review, U.S. Food and Drug Administration
JULIE KANESHIRO, Team Leader, Policy, Office for Human Research Protections, Department of Health and Human Services
STORY LANDIS, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Chair, NIH Stem Cell Task Force
BERNARD LO, Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco
GEOFF LOMAX, Senior Officer to the Standards Working Group, California Institute for Regenerative Medicine
OCR for page 18
Final Report of the National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research
JOHN MCNEISH, Executive Director, Pfizer Regenerative Medicine
P. PEARL O’ROURKE, Director of Human Research Affairs, Partners HealthCare System, Boston; and Associate Professor of Pediatrics, Harvard Medical School
SEAN TIPTON, Past-President, Coalition for the Advancement of Medical Research; and Director of Public Affairs, American Society for Reproductive Medicine
